-
Something wrong with this record ?
Effectiveness of treatment of arterial hypertension in Central Europe from 1972 to 2022
Arian Taniwall, Jan Broz, Michala Lustigova, Juan P. Gonzales-Rivas, Geraldo De Albuquerque Maranhao Neto, Iuliia Pavlovska, Pavlina Krollova, Barbora Berka, Ondrej Patek, Lucia Fackovcova, Petr Hoffmann, Jana Mlichova, Ludmila Brunerova, Jana Urbanova
Status minimal Language English Country Slovakia
BACKGROUND: Hypertension is a leading cause of cardiovascular disease. This review examines the literature on hypertension control in the Czech Republic from 1972 to 2022 addressing limited data on its effectiveness. METHODS: A literature review was conducted covering the period from 1972 to 2022, utilizing MEDLINE (PubMed), Web of Science, and Scopus databases. Articles were selected based on title and abstract evaluations, with full-text reviews performed as needed. Thirteen studies involving 44,990 participants were included in this review. RESULTS: Control rates increased from 2.8% (men) and 5.2% (women) in 1985 to 32.3% (men) and 37.4% (women) from 2015 to 2018. Women showed better blood pressure control. Specialised centres achieved higher success (48%) than general practitioners (18.4%). Diabetic patients had a lower percentage (29.1%) of patients meeting their target values (<130/80 mmHg) compared to non-diabetic patients, who had a higher percentage (60.6%) meeting their target values (<140/90 mmHg). CONCLUSION: Hypertension treatment success rate in the Czech Republic improved significantly over the last 50 years and is currently comparable to that of other European countries with similar healthcare resources. However, it still remains suboptimal and lags behind the countries with the most successful treatment outcomes (Tab. 3, Fig. 1, Ref. 37).
Department of Public Health Faculty of Medicine Masaryk University Brno Czech Republic
Foundation for Clinic Public Health and Epidemiology Research of Venezuela
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25012618
- 003
- CZ-PrNML
- 005
- 20250523164835.0
- 007
- cr|cn|
- 008
- 250523s2024 xo fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2024_48 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Taniwall, Arian $7 _AN120868 $u Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 10
- $a Effectiveness of treatment of arterial hypertension in Central Europe from 1972 to 2022 / $c Arian Taniwall, Jan Broz, Michala Lustigova, Juan P. Gonzales-Rivas, Geraldo De Albuquerque Maranhao Neto, Iuliia Pavlovska, Pavlina Krollova, Barbora Berka, Ondrej Patek, Lucia Fackovcova, Petr Hoffmann, Jana Mlichova, Ludmila Brunerova, Jana Urbanova
- 504 __
- $a Literatura
- 520 3_
- $a BACKGROUND: Hypertension is a leading cause of cardiovascular disease. This review examines the literature on hypertension control in the Czech Republic from 1972 to 2022 addressing limited data on its effectiveness. METHODS: A literature review was conducted covering the period from 1972 to 2022, utilizing MEDLINE (PubMed), Web of Science, and Scopus databases. Articles were selected based on title and abstract evaluations, with full-text reviews performed as needed. Thirteen studies involving 44,990 participants were included in this review. RESULTS: Control rates increased from 2.8% (men) and 5.2% (women) in 1985 to 32.3% (men) and 37.4% (women) from 2015 to 2018. Women showed better blood pressure control. Specialised centres achieved higher success (48%) than general practitioners (18.4%). Diabetic patients had a lower percentage (29.1%) of patients meeting their target values (<130/80 mmHg) compared to non-diabetic patients, who had a higher percentage (60.6%) meeting their target values (<140/90 mmHg). CONCLUSION: Hypertension treatment success rate in the Czech Republic improved significantly over the last 50 years and is currently comparable to that of other European countries with similar healthcare resources. However, it still remains suboptimal and lags behind the countries with the most successful treatment outcomes (Tab. 3, Fig. 1, Ref. 37).
- 700 1_
- $a Brož, Jan, $d 1963- $7 xx0046397 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Lustigová, Michala $7 xx0135529 $u Department of Social Geography and Regional Development, Faculty of Science, Charles University, Prague, Czech Republic $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Gonzales-Rivas, Juan P. $7 _AN122619 $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Brno, Czech Republic $u Departments of Global Health and Population. Harvard TH Chan School of Public Health. Harvard University $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC.)
- 700 1_
- $a Neto, Geraldo A. Maranhao $7 xx0305462 $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Brno, Czech Republic
- 700 1_
- $a Pavlovska, Iuliia $7 _AN113162 $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Brno, Czech Republic $u Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Krollová, Pavlína $7 xx0229419 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Berka, Barbora $7 xx0318384 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Pátek, Ondřej $7 xx0283341 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Fačkovcová, Lucia, $d 1993- $7 xx0309995 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Hoffmann, Petr $7 xx0245612 $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Mlíchová, Jana $7 _AN079848 $u Department of Pharmacology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Brunerová, Ludmila, $d 1978- $7 xx0106043 $u Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Urbanová, Jana, $d 1984- $7 xx0225255 $u Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 125, č. 5 (2024), s. 322-330 $w MED00000845
- 856 41
- $u https://www.elis.sk/download_file.php?product_id=8259&session_id=j7f72aa2f52eag91f55b81k442 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 1067 $y 0 $z 0
- 990 __
- $a 20250523113445 $b ABA008
- 991 __
- $a 20250523164834 $b ABA008
- 999 __
- $a min $b bmc $g 2326205 $s 1249725
- BAS __
- $a 3 $a 4
- BMC __
- $a 2024 $b 125 $c 5 $d 322-330 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
- LZP __
- $a NLK 2025-11/kv
